Effect of N-acetylcysteine in moderate to severe traumatic brain injury

Phase 3

Recruiting

• Conditions: S06.2; Traumatic Brain Injury.; Diffuse traumatic brain injury

• Registration Number: IRCT20230815059150N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 16 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients with moderate to severe traumatic brain injury
Patients over 18 years of age

Exclusion Criteria

Patients with Glasgow Coma Scale 3

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The effect of NAC on the Glasgow Coma Scale (GCS) of patients with moderate to severe traumatic brain injury. Timepoint: 7 Days. Method of measurement: table of Glasgow Coma Scale.;The effect of NAC on the Glasgow Outcome Scale (GOS) of patients with moderate to severe traumatic brain injury. Timepoint: 7 Days. Method of measurement: Table of Glasgow Outcome Scale.;The effect of NAC on the Modified Rankin Scale (mRS) of patients with moderate to severe traumatic brain injury. Timepoint: 7 days. Method of measurement: Table of Modified Rankin Scale (mRS).